Wernicke's encephalopathy in non-alcoholics: An autopsy study

https://doi.org/10.1016/0022-510X(89)90095-6Get rights and content

Abstract

In a 5-year autopsy material constituting 6 964 autopsies, there were 52 cases of Wernicke's encephalopathy of which 12 (23%) occurred in non-alcoholics. Among 18 cases with active (acute) disease, 7 cases (39%) were found in non-alcoholics. Only 4 cases of active Wernicke's disease were diagnosed clinically, all of them in alcoholics. The predominant clinical symptoms were disorientation and depressed levels of consciousness, whereas eye symptoms were recorded in only 3 cases. None of the non-alcoholics were given specific thiamine therapy, whereas some alcoholics received large doses of the vitamin as a routine procedure. However, the thiamine therapy was often instituted too late. It is concluded that active Wernicke's encephalopathy should be considered in all patients with prolonged malnutrition and that disorientation and depressed levels of consciousness may be the predominating symptoms of the disease. Even the slightest suspicion of Wernicke's encephalopathy should prompt immediate administration of large doses of thiamine parenterally.

References (11)

There are more references available in the full text version of this article.

Cited by (78)

  • A randomized double-blind placebo-controlled trial of intravenous thiamine for prevention of delirium following allogeneic hematopoietic stem cell transplantation

    2021, Journal of Psychosomatic Research
    Citation Excerpt :

    WE has become increasingly recognized across many medical conditions and settings [14,16–19], including after HSCT [20–22]. However, accurate estimates of its prevalence in HSCT and in most other medical populations are lacking, as the clinical triad of ophthalmoplegia, ataxia, and mental status changes are observed in fewer than 20% of affected patients [23–25]. High dose intravenous (IV) thiamine, defined as at least 200 mg IV three times daily (TID) until symptoms resolve, is recommended for treatment of WE [26–28], and has preliminary evidence for improving a variety of cognitive symptoms in oncology inpatient settings [29,30].

  • Design of a randomized placebo controlled trial of high dose intravenous thiamine for the prevention of delirium in allogeneic hematopoietic stem cell transplantation

    2020, Contemporary Clinical Trials
    Citation Excerpt :

    WE is a condition, classically described in chronic alcoholism, in which thiamine deficiency leads to a triad of clinical signs, including ophthalmoplegia, ataxia, and mental status changes. However, all three signs are identified in fewer than 20% of affected patients [7–9]. In the past 20 years, awareness of the potential for thiamine deficiency to lead to delirium without the other physical signs of WE has increased [10,11].

  • Thiamin

    2017, Advances in Nutrition
  • Wernicke's encephalopathy: A rare complication of hyperemesis gravidarum

    2015, Anaesthesia Critical Care and Pain Medicine
  • Gastrointestinal Surgery and Wernicke Encephalopathy

    2015, Diet and Nutrition in Dementia and Cognitive Decline
View all citing articles on Scopus
View full text